Vident Advisory’s Axogen AXGN Stock Holding History

Vident Advisory’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401K	Buy	8,674 +1,313	+18%	+$52.9K	﹤0.01%	1478
2026 Q1	$244K	Buy	+7,361	New	+$239K	﹤0.01%	1596

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vident Advisory's AXGN Position: Q2 2026 in Review

Vident Advisory increased its Axogen (AXGN) stake by 18% in Q2 2026, buying an estimated $52.9K and bringing the position to 8,674 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1478.

Vident Advisory first reported a position in AXGN in Q1 2026 and has held it in 2 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

Vident Advisory held 8,674 shares of Axogen worth $401K as of Q2 2026.
Vident Advisory bought 1,313 Axogen shares in Q2 2026, an estimated $52.9K.
Axogen made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1478 holding.
Vident Advisory first reported a position in Axogen in Q1 2026 and has held it in 2 quarters since.
253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.